Are you Dr. Tfayli?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 41 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
825 Ne 10th St
Oupb 5200
Oklahoma City, OK 73104Phone+1 405-271-8299
Summary
- Dr. Arafat Tfayli, MD is an oncologist in Oklahoma City, Oklahoma. He is currently licensed to practice medicine in Oklahoma, Nebraska, and District of Columbia. He is affiliated with Great Plains Health.
Education & Training
MedStar Health/Georgetown University HospitalFellowship, Hematology and Medical Oncology, 1999 - 2002
Stony Brook Medicine/University HospitalResidency, Internal Medicine, 1995 - 1999
American University of Beirut Faculty of MedicineClass of 1995
Certifications & Licensure
DC State Medical License 1999 - Present
NE State Medical License 2022 - 2026
OK State Medical License 2002 - 2010
MD State Medical License 1998 - 2003- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Neoadjuvant Compound 121564 Plus Platinum Doublet Chemotherapy in Non-Small Cell Lung Cancer Start of enrollment: 2018 Jun 26
Publications & Presentations
PubMed
- 1 citationsACTH-secreting metastatic prostate cancer with neuroendocrine differentiation.Bashar Hassan, Yara Yazbeck, Vanessa Akiki, Ibrahim Salti, Arafat Tfayli
BMJ Case Reports. 2022-12-19 - 8 citationsMulti-disciplinary approach for the management of non-metastatic non-small cell lung cancer in the Middle East and Africa: Expert panel recommendations.Erdem Göker, Abdullah Altwairgi, Ameen Al-Omair, Arafat Tfayli, Edward Black
Lung Cancer. 2021-05-26 - 11 citationsPrevalence of EGFR and ALK Mutations in Lung Adenocarcinomas in the Levant Area - a Prospective AnalysisArafat Tfayli, Hind Rafei, Alain Mina, Maya Khalil, Najla Fakhreddin
Asian Pacific Journal of Cancer Prevention. 2017-01-01
Press Mentions
Barriers to Widespread Access to Cancer Medications Include Excessive CostNovember 20th, 2024- Check Your Breasts for Breast Cancer Awareness MonthJanuary 10th, 2021
